Clinical snapshot. 63F, postmenopausal, with bilateral 1st CMC osteoarthritis, multiple right toe pain (uncharacterised), and left lumbar-radicular thigh pain that was 80% of her April complaint. A 10-day medication course (Aceclofenac + Paracetamol + Chlorzoxazone, Pregabalin 75 + Nortriptyline 10 + Methylcobalamin 1500, Rabeprazole + Domperidone, Cholecalciferol oral + 300,000 IU IM) finished ~28 Apr 2026. Pain has substantially improved; constipation resolved; she is currently off all prescription medication. Round 2 labs (19 May 2026) ruled out Hashimoto's (Anti-TPO & Anti-Tg both <3), insulin resistance (HOMA-IR 0.89), and intestinal parasites; rheumatoid arthritis is much less likely (Anti-CCP 0.90 — note lab sensitivity 70.6%). B12, TSH, CRP, Calcium and Fasting Glucose have all normalised. Three residual threads remain: elevated homocysteine, borderline-high triglycerides + low HDL, and high-normal PTH. We are seeking your assessment of these threads and your sign-off on the plan below.
Plan adversarially reviewed against AGS Beers Criteria 2023, STOPP/START v3, WHO/CDC older-adult activity guidance, ACR/Arthritis Foundation 2019 OA guideline, PROT-AGE/ESPEN protein guidance, and the published positions of Attia, Huberman, Willett, Longo, Wright, McGill, Fried and Tinetti. Cardinal rule: we do not prescribe, start or stop prescription medication — that is yours.
North Star — 12 Months (May 2027)
| Marker | May 2026 | 12-mo target | Lever |
|---|
| HbA1c (%) | 6.3 | <5.7 | Post-meal walks · meal sequencing · weight stable |
| TSH (µIU/mL) | 4.526 | durably <4.0 | Re-test at 3 mo; no thyroid drug needed if stable |
| HDL (mg/dL) | 40 | >45 | Strength training · omega-3 · weight |
| Triglycerides (mg/dL) | 168 | <150 | Reduce refined starch · post-meal walks |
| Homocysteine (µmol/L) | 17.19 | <10 | Folate / B6 status workup → cofactor strategy |
| CRP, Quant (mg/L) | 2.30 | <3.0 | Already met — maintain |
| B12 (pg/mL) | 361 | >400 sustained | Diet first; re-check off-supplement |
| BP | missing | <130/80 | Home cuff log → ASCVD assessment |
| Weight / waist | missing | Stable, no muscle loss | Weekly weigh-in starting this week |
| Falls (last 6 mo) | 0 | 0 | Balance drills · home-hazard audit · no sedating drugs |
| Hospitalizations (12 mo) | 0 | 0 | Hard floor |
Top 3 actions this week (Ravi-owned)
- Start BP + weight + waist tracking. Weekly weigh-in (morning, post-toilet, pre-food). BP cuff: seated, 2 readings, 3 days/week for the first month. Without these, neither HbA1c nor triglyceride trajectories can be interpreted.
- Book DEXA and ECG. DEXA is the gate that loosens resistance-training restrictions. ECG is the baseline before any future QT-risk prescription. Neither has a current symptom blocking it; both are missing baselines.
- Clarify K2-GOOD (calcitriol) and T. Castrou. Photograph her medicine cabinet; ask the pharmacy / prescribing doctor. Until we know the prescriber and indication, both remain unresolved drug-interaction risks.
Lab Trajectory (Nov 2025 → May 2026)
| Marker | Nov 2025 | May 2026 | Reference | Status |
|---|
| TSH (µIU/mL) | 7.275 | 4.526 | 0.55–4.78 | Normalised |
| Vitamin B12 (pg/mL) | 170 | 361 | 211–911 | Corrected |
| Vitamin D, 25-OH (ng/mL) | 40.2 | 42.9 | ≥30 | Sufficient |
| Calcium (mg/dL) | 8.3 | 8.9 | 8.7–10.4 | Normalised |
| Fasting Glucose (mg/dL) | 103 | 95 | 70–99 | Normalised |
| CRP Quant (mg/L) | 5.30 | 2.30 | 0–3.3 | Normalised |
| HbA1c (%) | 6.2 | 6.3 | <5.6 | Post-prandial |
| Homocysteine (µmol/L) | 18.66 | 17.19 | 3.7–13.9 | Cofactor gap |
| HDL (mg/dL) | 34 | 40 | ≥50 (women) | Low; improving |
| Triglycerides (mg/dL) | 124 | 168 | <150 | Borderline-high |
| Potassium (mEq/L) | 4.48 | 3.62 | 3.5–5.1 | Low-normal |
| AST / ALT (U/L) | 30 / 29 | 36 / 37 | <34 / 10–49 | AST mildly up |
| PTH Intact (pg/mL) | — | 78.60 | 18.4–80.1 | High-normal |
| Lp(a) (mg/dL) | 42.90 | — (not retested) | <30 | Genetic / elevated |
| Anti-TPO / Anti-Tg (IU/mL) | — | <3 / <3 | <5.61 / <4.11 | Negative |
| Anti-CCP (U/mL) | — | 0.90 | <5.0 | Negative |
| HOMA-IR | — | 0.89 | <2.5 | Optimal |
| Magnesium (mg/dL) | — | 2.07 | 1.30–2.70 | Normal |
| IgE Total (IU/mL) | 299 | missed | <158 | Re-test pending |
1. Nutrition — Ranchi-adapted, age-specific
Diagnosis-led levers: post-prandial glucose control (not insulin sensitisation — HOMA-IR is optimal), HDL / TG correction, homocysteine cofactor support (folate / B6 / choline foods), food-first bone support until DEXA, sustained protein for sarcopenia prevention. Evidence A/B for protein, food order, plant-forward pattern
Daily Template (Indian, anti-inflammatory, post-prandial-aware)
| Time | Default meal | Portion guide |
|---|
| On waking | 300–500 ml warm water (lemon if tolerated) | 1 large glass |
| Breakfast | Besan chilla + curd · or 2 eggs + veg poha · or daliya with curd & nuts · or sattu + sprouts | 20–25 g protein; starch modest |
| Mid-morning | 1 seasonal fruit + nuts · or chaas · or papaya (if any bowel slowing) | Fruit 1 fist; 8–10 almonds or 2 walnuts |
| Lunch (main meal) | Order: salad → dal/curd/paneer → roti/rice last. 2 sabzi. Eat slowly. | Dal 1–1½ katori · roti 1–2 phulka OR rice ½ cup cooked (not both) · curd 1 katori |
| Evening | Roasted chana · makhana · sprouts chaat · sattu drink · unsweetened tea | Avoid biscuit / namkeen default |
| Dinner (lighter) | Paneer / curd / dal / egg / fish + cooked veg + 1–2 phulka OR ragi roti / millet khichdi | Finish by 19:30–20:00 when feasible |
| Bedtime (if hungry) | Haldi milk no sugar · or plain warm milk | 100–150 ml; only if reflux/glucose tolerate |
Food order at lunch & dinner: vegetables → protein → starch. Walk 5–10 min within 30 min after meals. This is the specific lever for the HbA1c (6.3) + FBS (95) + HOMA-IR (0.89) "post-prandial spike" pattern.
Daily targets
- Protein: 1.0–1.2 g/kg body weight (~60–72 g/day if 60 kg). Split across 3 meals.
- Hydration: 2.5–3.0 L/day adapted for Ranchi heat.
- Salt: <5 g/day total (includes pickle, papad, namkeen).
- Free sugar: <25 g/day.
- Fibre: dal + seasonal veg + 1 tbsp ground flaxseed.
Lever-specific foods
- HDL ↑: mustard or olive oil, walnuts, flax, fish (if eaten), oats, sattu.
- Homocysteine ↓: saag, methi, chana, masoor, peanuts, citrus, amla, eggs, beetroot, sweet potato.
- Bone (food-first): curd, ragi, til, paneer, leafy greens, almonds.
- K⁺ (3.62): banana, coconut water, dal, spinach, sweet potato, tomato, curd.
- Anti-inflammatory: turmeric + black pepper + fat (culinary doses only — high-dose curcumin held until AST normalises).
2. Supplements — Post-Round-2 (4-tier framework)
Rule: the supplement plan collapsed after Round 2 because the deficiencies and disease states that drove the prior stack were either ruled out or already corrected by her doctor's regimen. Most items are now not indicated. Below is the curated remainder.
Tier A — OTC / food-like, can start now (low risk)
| Item | Form & dose | Indication |
|---|
| Psyllium (Isabgol) | Plain husk, 1 tsp in warm water at bedtime | Constipation rescue / prevention if bowel slows; safe rescue tool |
| Ground flaxseed | 1 tbsp/day on curd or daliya | Plant omega-3, fibre, modest TG/HDL support |
| Culinary turmeric + black pepper + fat | ¼–½ tsp turmeric, cooked into food | Anti-inflammatory pattern without high-dose capsule burden |
| Morning sunlight | 10–20 min within 30 min of waking | Circadian anchoring, Vit D maintenance, mood |
Tier B — Discuss with doctor before starting
| Candidate | Form & dose | Why on the table | Caveat |
|---|
| Methylated B-complex | 5-MTHF folate + methylcobalamin + P5P B6 (B6 capped ≤10–25 mg/day) | Hcy 17.19 despite B12 361; folate / B6 status not yet measured | Order RBC folate + B6 first if possible |
| Omega-3 (EPA+DHA) | 1–2 g/day, third-party tested | TG 168 · HDL 40 · Lp(a) 42.9 — modest benefit, not a cure | Bleeding caveat if any future NSAID / surgery |
| Curcumin (bioavailable) | 500 mg/day trial | Conditional for residual joint pain | HOLD until AST normalises (currently 36) |
| Boswellia serrata | 300 mg 1–2× day, standardised AKBA | Conditional for persistent joint pain (CRP already normal) | Symptom-driven only |
| Glucosamine sulfate | 1500 mg/day, 8–12 week trial | Conditional for CMC OA | Evidence mixed for hand OA |
| TMG / Betaine | 500–1000 mg/day | Alternative Hcy pathway if cofactors don't move it | Only after B12 / folate / B6 optimised |
Tier C — HOLD pending repeat labs / DEXA / clarification
| Item | Why on hold |
|---|
| Vitamin D3 maintenance pill | Already sufficient (42.9 ng/mL) after loading — re-check Aug 2026 before adding more |
| Vitamin K2 (MK-7) standalone | Risk of stacking / confusion with K2-GOOD (which contains calcitriol) |
| Calcium supplement | Serum calcium normalised (8.9); food-first; CV calcification + constipation risk in postmenopausal women |
| UC-II collagen / SAMe / quercetin | Not core; revisit only with specific indication |
Tier D — REMOVED from plan (Round 2 ruled out the indication)
| Item | Reason removed |
|---|
| Selenium | Anti-TPO & Anti-Tg both negative — no autoimmune thyroid driver |
| Alpha-lipoic acid | HOMA-IR 0.89 — no insulin resistance |
| Magnesium supplement | Serum Mg 2.07 mid-range normal |
| Iron supplement | Ferritin 50.5, Hb 12.6 — no iron-deficiency anaemia |
| High-dose iodine / thyroid boosters | TSH normalised; risk of destabilising thyroid |
Roll-out discipline (if doctor approves any Tier B)
Add one new supplement every 7–14 days. After AST normalises → consider curcumin / Boswellia. After DEXA + PTH/Ca/Vit D repeat → decide on D3/K2/calcium.
3. Bloodwork & Imaging — 3 / 6 / 12-month cadence
At-home tracking — start this week
| Metric | Frequency | Method |
|---|
| Weight | Weekly | Same scale, morning, post-toilet, pre-food |
| Waist | Monthly | Tape at navel |
| BP | 3×/week first month, weekly after | Validated home cuff, seated, 2 readings |
| Pain score (hand / thigh / foot) | Weekly | 0–10 each region |
| Falls / near-falls | Immediate log | Date, trigger, injury, dizziness |
3-month retest — Aug 2026
Tata 1mg home collection (fasting):
- HbA1c · Fasting Glucose · Fasting Insulin + HOMA-IR repeat
- TSH · Free T4
- B12 · Homocysteine
- RBC Folate (or serum) · B6 (PLP) — new tests for Hcy workup
- CBC with RDW · hs-CRP + CRP
- Lipid panel + ApoB (new — better than LDL alone given Lp(a) elevated)
- CMP / KFT / LFT (AST follow-up) · electrolytes incl. K⁺
- Cystatin C (new — better eGFR in elderly)
- Ca · Phosphorus · 25-OH Vit D · PTH (repeat)
- IgE Total (re-order — was missed in Round 2)
Non-blood — book within 3 months
- DEXA scan (with FRAX) — gate for resistance-training restrictions
- ECG 12-lead — baseline before any future QT-risk drug
- Comprehensive eye exam — glaucoma / cataract / retina baseline
- Dental + periodontal exam — inflammation source check
- Audiometry — falls / cognition / social function
- Mammography · Pap/HPV · Colonoscopy — confirm last dates with doctor
- Retrieve April hand / L-S spine / foot X-ray reports
6-month (Nov 2026) & 12-month (May 2027)
Same panel with continuing trend focus; antibodies repeated only if clinical reason; full Lp(a) re-test once-yearly at 12 mo.
Do NOT routinely repeat: Anti-TPO · Anti-Tg · Anti-CCP · Serum Magnesium · broad allergy panels — Round 2 closed these questions.
4. Exercise — Holistic, joint-safe, spine-aware
Weekly minimums
| Domain | Target | Intensity |
|---|
| Zone 2 cardio (brisk walk) | 150–180 min/week | Can talk in short sentences; cannot sing comfortably |
| Resistance training | 2 sessions/week | Easy-to-moderate, pristine form |
| Balance / fall prevention | 5–10 min/day + 1 longer session/week | Near a wall or counter |
| Therapeutic yoga / mobility | 15–20 min/day | Gentle, no aggressive end-range (see §5) |
| Post-meal walks | 5–10 min after lunch & dinner | Slow to moderate |
Resistance menu — no loaded spine until DEXA + ortho clearance
| Exercise | Start | Progress to |
|---|
| Sit-to-stand | Chair, arms allowed | Arms crossed → light goblet (after clearance) |
| Wall push-up | Hands high on wall | Counter push-up (avoid floor — CMC pain) |
| Banded row | Light resistance band | Stronger band |
| Glute bridge | Bodyweight | Band above knees |
| Banded clamshell | Light band | More reps / stronger band |
| Calf raise (supported) | Hold wall/chair | Single-leg supported |
| Dead-bug heel taps | Small range | Full dead-bug (McGill Big 3) |
| Modified curl-up + side bridge + bird-dog | McGill Big 3 starter | Hold time progression |
12-week progression
| Weeks | Cardio | Strength | Balance |
|---|
| 1–2 | 20 min × 5 days | 1 light session/wk | 5 min/day |
| 3–4 | 25–30 min × 5 days | 2 light sessions/wk | 5–8 min/day |
| 5–8 | 30 min × 5–6 days | 2 sessions/wk, add bands | 8–10 min/day |
| 9–12 | 150–180 min/wk | 2–3 sessions/wk if recovery good | Add Tai Chi weekly |
Progress only if: pain doesn't increase next day · no new leg weakness/numbness/gait change · no dizziness or near-falls · sleep & appetite stable.
5. Yoga — Iyengar therapeutic (prop-supported)
Rule: yoga is for breath, mobility, balance and parasympathetic down-regulation. Not for performance. Walls, chairs, bolsters, straps and blocks are mandatory until DEXA + spine clearance.
Morning — 20 min
- 1 min — Quiet standing + breath at wall
- 2 min — Tadasana at wall
- 2 min — Shoulder rolls + wrist circles
- 3 min — Marjaryasana–Bitilasana (chair / forearms if wrists hurt)
- 3 min — Wall-supported Adho Mukha (hands on wall, hips back)
- 4 min — Supta Padangusthasana with strap (gentle)
- 3 min — Setu Bandha with block / bolster
- 2 min — Nadi Shodhana (no breath holds)
Evening — 15 min
- 3 min — Supta Baddha Konasana on bolster
- 3 min — Supine spinal twist (knees stacked on bolster)
- 3 min — Janu Sirsasana light with strap (no deep fold)
- 4 min — Viparita Karani (legs up wall — not shoulderstand)
- 2 min — Bhramari + Savasana
Pranayama rotation
Nadi Shodhana (3–5 min) · Bhramari (3–5 min evening) · slow nasal breathing 6 bpm · extended-exhale 4-in / 6-out. No breath retention.
Expert Panel Agreement Matrix
Each plan element is checked against the published positions of ten authorities. Where the panel is unanimous (or near-unanimous), the recommendation is considered safe to act on now. Where it is contested, it is flagged and held as a doctor-discussion item.
Symbols:
✓ supports ·
~ caveat / conditional ·
✗ disagrees ·
— not central to their work
Panel columns (hover to expand):
AT Attia ·
HU Huberman ·
WI Willett ·
LO Longo ·
WR Wright ·
MG McGill ·
FR Fried ·
BS Beers/STOPP ·
RU Rujuta ·
IY Iyengar
| Recommendation |
AT |
HU |
WI |
LO |
WR |
MG |
FR |
BS |
RU |
IY |
Ev |
| Exercise & Movement |
| Zone 2 walking 150–180 min/wk |
✓ | ✓ | ✓ | ✓ |
✓ | ~ | ✓ | ✓ |
✓ | — | A |
| Resistance training 2×/week |
✓ | ✓ | ✓ | ✓ |
✓ | ~ | ✓ | ✓ |
✓ | — | A |
| Balance / Tai Chi / fall prevention |
✓ | — | — | — |
✓ | ✓ | ✓ | ✓ |
✓ | ~ | A |
| McGill Big 3 spine stability |
~ | — | — | — |
✓ | ✓ | ✓ | ✓ |
— | ~ | B/C |
| Avoid heavy loaded spine until DEXA / ortho |
✓ | — | — | — |
✓ | ✓ | ✓ | ✓ |
— | ✓ | D |
| Nutrition |
| Protein 1.0–1.2 g/kg/day (floor) |
~ | — | ✓ | ✓ |
✓ | ✓ | ✓ | — |
✓ | — | A/B |
| Protein 1.6 g/kg upper bound (contested) |
✓ | — | ~ | ~ |
✓ | ✓ | ✓ | — |
~ | — | C |
| Mediterranean / plant-forward Indian pattern |
✓ | ✓ | ✓ | ✓ |
✓ | — | ✓ | — |
✓ | — | A |
| Post-meal walks + starch-last food order |
✓ | ✓ | ✓ | ✓ |
✓ | — | ✓ | — |
✓ | — | A/B |
| Supplements & Bloodwork |
| Food-first calcium + DEXA before Ca pills |
✓ | — | ✓ | ✓ |
✓ | ✓ | ✓ | ✓ |
✓ | — | A/B |
| Hold Vit D maintenance until retest |
✓ | — | ✓ | ~ |
✓ | — | ✓ | ✓ |
— | — | B |
| Remove selenium after negative antibodies |
✓ | — | ✓ | ✓ |
— | — | — | ✓ |
— | — | B |
| Remove ALA — no insulin resistance shown |
✓ | — | ✓ | ✓ |
— | — | — | ✓ |
— | — | B |
| Omega-3 for TG/HDL/CV (contested) |
✓ | — | ✓ | ✓ |
~ | — | — | ~ |
~ | — | A/B |
| Methylated B-complex for residual Hcy (contested) |
✓ | — | ~ | ~ |
— | — | — | ~ |
~ | — | B/C |
| Curcumin / Boswellia if pain persists + AST ok (contested) |
~ | — | ~ | ~ |
✓ | — | — | ~ |
✓ | — | C |
| Yoga & Mind / Body |
| Iyengar prop-supported gentle yoga |
— | ✓ | — | — |
✓ | ~ | ✓ | ✓ |
✓ | ✓ | B/C |
| Avoid inversions & power yoga |
— | — | — | — |
✓ | ✓ | ✓ | ✓ |
— | ✓ | D |
| Sleep · Circadian · Social |
| Sleep window + morning sunlight |
✓ | ✓ | — | ✓ |
— | — | ✓ | — |
✓ | ✓ | B/C |
| Daily social contact + PHQ-9 / 6 mo |
✓ | ✓ | — | — |
— | — | ✓ | ✓ |
✓ | — | A/B |
| Safety Posture |
| No 1st-gen antihistamine sleep aids |
✓ | ✓ | — | — |
✓ | — | ✓ | ✓ |
— | — | A |
| No prescription start / stop / change without doctor |
✓ | ✓ | ✓ | ✓ |
✓ | ✓ | ✓ | ✓ |
✓ | ✓ | D |
Contested rows — flagged for doctor discussion, not auto-start
- Protein 1.6 g/kg upper bound: Attia / Wright push higher for muscle preservation; Longo / Willett more cautious about excess animal protein. Compromise: hold at 1.0–1.2 g/kg until weight, cystatin C, and sarcopenia screen are available.
- Methylated B-complex for residual Hcy: mechanistically plausible (Hcy 17.19 despite B12 361), but folate / B6 not yet measured. Treat as doctor-discussion item, not automatic start.
- Omega-3 for TG / HDL / Lp(a): reasonable case (TG 168, HDL 40, Lp(a) 42.9), but effect size is modest and bleeding / NSAID / surgery context matters.
- Curcumin / Boswellia: symptom trial only. CRP already normal; AST must normalise before high-dose curcumin.
⚠ What NOT to do — Master Safety Net
Compiled against AGS Beers 2023 + STOPP/START + her specific profile: postmenopausal, prior TCA exposure, K⁺ 3.62, AST 36, elevated Hcy, no DEXA, no BP baseline.
Medications — ask before any new Rx
- TCAs & strongly anticholinergic drugs (amitriptyline, imipramine, doxepin, oxybutynin) — prior Nortriptyline caused predictable constipation
- Benzodiazepines & Z-drugs (alprazolam, clonazepam, diazepam, zolpidem) — falls / confusion / dependence
- Skeletal muscle relaxants (chlorzoxazone, cyclobenzaprine, thiocolchicoside) — fall stack
- Gabapentinoids (pregabalin, gabapentin) — sedation, edema, weight, falls if chronic
- QT-prolonging combinations (TCA + domperidone, macrolides, fluoroquinolones) — request ECG & electrolytes first
- Domperidone repeats — QT risk; ask for safer alternative
- Oral NSAIDs as chronic therapy (aceclofenac, diclofenac, ibuprofen, naproxen, etoricoxib) — prefer topical diclofenac gel for CMC OA per ACR
- Aspirin for primary prevention — no ASCVD calc done yet
- Chronic PPI beyond NSAID protection course
- Systemic steroids for joint pain without firm diagnosis
- 1st-gen antihistamines (diphenhydramine, chlorpheniramine, hydroxyzine, promethazine) — anticholinergic / sedating
- Opioids / tramadol — falls + constipation; should be last resort with shortest duration
- Calcitriol / alfacalcidol products — K2-GOOD overlap risk; not a routine supplement
Supplements — never take
- K2-GOOD as a casual K2 product (contains calcitriol + calcium)
- Repeat 60,000 IU vitamin D loading or injections
- Calcium tablets without DEXA + repeat Ca/PTH plan
- Selenium · Alpha-lipoic acid · Iron tablets — Round 2 ruled out the indications
- High-dose iodine, kelp, thyroid glandular products
- High-dose B6 (>100 mg/day) — paradoxical neuropathy
- High-dose curcumin while AST is mildly elevated
- St John's Wort · 5-HTP · tryptophan — interaction risk with future Rx
- "Joint pain" mixes / undisclosed Ayurvedic bhasma — hidden steroid / heavy-metal risk
- Daily stimulant laxatives (senna, bisacodyl) — habit-forming, motility damage
- Fat burners · garcinia · green-tea-extract capsules — liver / BP risk
- Ginkgo / high-dose omega-3 / garlic pills around any future surgery or NSAID — bleeding stack
Exercise — avoid until DEXA + ortho clearance
- Heavy back / front squats · deadlifts · kettlebell swings · loaded good-mornings
- Loaded forward bends · any flexion-under-load
- Sit-ups · crunches · Russian twists
- Running · jumping · burpees · box jumps · plyometrics
- Floor planks / push-ups loading painful CMC thumbs
- Group HIIT / power-yoga / bootcamp without instructor able to modify for sciatica + CMC
- "Pushing through" exercise on painkillers — pain reduction masks tissue limits
Yoga — avoid (consolidated)
- Sirsasana · Sarvangasana · Halasana · Karnapidasana — neck / cervical load
- Pincha Mayurasana · Bakasana · Mayurasana · Chaturanga-heavy flows — CMC + wrist load
- Urdhva Dhanurasana / full wheel — spine extension under load
- Deep Padottanasana · deep Paschimottanasana — lumbar flexion
- Fast Surya Namaskar · heated / power yoga
- Vigorous Bhastrika or Kapalabhati · breath retention — BP / cerebral pressure
Foods to limit (not absolute bans)
- Sugary chai → no sugar; total free sugar <25 g/day
- Sweets (rasgulla, gulab jamun, jalebi, laddu, barfi) — occasion only, 2–3 bites
- White rice — ½ cup cooked if also eating roti; avoid rice + multiple rotis + potato in one meal
- Namkeen · bhujia · chips · papad · pickle — not daily
- Deep-fried snacks · fruit juice · bakery biscuits as default tea snack
- Late large dinner (within 3 hr of bedtime) — worsens glucose, sleep, reflux
Lifestyle pitfalls (frailty accelerators)
- No weight / BP tracking — hides deterioration
- Fear-based inactivity after pain improves — accelerates sarcopenia + glucose worsening
- Skipping breakfast protein — common in elderly Indian women on "light food" mindset
- Social isolation — Ravi remote ≠ local care; protocol needed
- Dehydration to reduce urination — worsens constipation, dizziness, K⁺
- Keeping old prescriptions "for later" — NSAIDs, TCAs, antibiotics, steroids especially
- Treating every lab blip with a supplement — pill burden, hides causes
- Ignoring dental / vision / hearing — these are aging-risk multipliers, not cosmetic
The 5 questions before any new prescription
- What is the exact diagnosis or symptom target?
- What is the planned duration and stop / review date?
- Does this drug increase falls, constipation, confusion, QT prolongation, kidney strain, liver strain, BP, glucose, or bleeding?
- Does it interact with K2-GOOD / calcitriol possibility or her current labs (K⁺ 3.62, AST 36, HbA1c 6.3, PTH 78.6)?
- What monitoring is needed (ECG, electrolytes, BP, LFT/KFT, bowel plan, fall precautions)?
Top Questions for the Doctor (this visit)
- Homocysteine 17.19 despite B12 361. Should we order RBC folate + plasma B6 (PLP) before considering 5-MTHF / P5P / TMG, or would you prefer an empiric methylated B-complex trial?
- PTH 78.60 (high-normal) with Ca 8.9 + Phosphorus 5.10. Would you recommend DEXA + FRAX now, with repeat Ca / Phosphorus / Vit D / PTH at 3 months and 24-hr urinary calcium if PTH stays high?
- Pre-diabetes pattern. Given HbA1c 6.3 with FBS 95 and HOMA-IR 0.89, is meal sequencing + post-meal walks for 3 months sufficient, or should we start with an OGTT / short CGM trial now?
- Lipid risk. With Lp(a) 42.9, HDL 40, TG 168, and missing BP, would you add ApoB at the next draw and base CV-risk decisions on it rather than LDL alone?
- Bilateral 1st CMC OA. Would you support thumb CMC orthosis (ACR strong recommendation), hand-therapy referral, and topical diclofenac 1% gel for breakthrough pain — in preference to oral NSAIDs?
- K2-GOOD (Calcitriol 0.25 mcg + Ca + K2-7). Whose prescription, what indication? Should it continue, pause, or stop after the recent cholecalciferol loading?
- T. Castrou. Composition could not be verified by us — could you confirm what it was for so we know whether it is needed in future?
- AST 36 (mildly elevated). Repeat LFT (ALT / GGT / CK) in 4–6 weeks, or sooner? Fatty-liver screen given pre-diabetes + TG drift?
- IgE retest. Was 299 in Nov 2025, missed in Round 2. Order now or only if symptoms?
- Sciatica resolved with the April course. MRI L-S spine indicated now as precaution, or watch-and-wait with red-flag monitoring (new leg weakness, bladder/bowel change, gait change)?
Review Cadence
| When | Purpose | Decision trigger |
|---|
| 4 weeks (late Jun 2026) | Adherence + safety check | Simplify what isn't being followed; do not add new supplements |
| 3 months (Aug 2026) | First outcome retest (see §3) | If HbA1c worsens → CGM/OGTT discussion · If Hcy >15 → cofactor strategy · If AST stays high → hold curcumin, fatty-liver workup |
| 6 months (Nov 2026) | Mid-cycle durability + plan pruning | Keep only supplements with clear indication + no side effects |
| 12 months (May 2027) | Year-1 outcome vs Nov 2025 baseline | Write Year-2 plan from measured response · drop low-value tracking |